chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe stomach cramps, headache, sweating, severe, uncontrollable diarrhea, vomiting, tingle/chills.
Pt recvd 3 doses of Engerix-B 30OCT90, 26NOV90, 6MAY91 & 17SEP91 it was determined that pts titer was neg p/3 doses of Engerix-B;
Patient says she experienced a sore arm and pain in shoulder that never went away. She believes it was from vaccine.  She has pain in shoulder in middle of the night and states throbbing.
Had flu shot at mass event. 4 hrs later had chest pain, nausea and SOB. Numbness to right side of her face. To ER. Admitted to hospital for assessment for 10 days.
Starting the following day I had muscle achis muscle aches lethargy E and sputum and a cough that has continued for the past 14 days since receiving the vaccine
local rxn of swelling, redness, tenderness very large : below to axilla area;described as painful all noc;
expired vaccine used; incorrect product storage; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and PRODUCT STORAGE ERROR (incorrect product storage) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 088D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and PRODUCT STORAGE ERROR (incorrect product storage). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) and PRODUCT STORAGE ERROR (incorrect product storage) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication were reported.The vial was suppose to be wasted since it was set to expire after the 12 hour mark at 10:30PM 17-Sep-2021 (Friday). However, no one was available to throw it in the waste. Accidentally, yesterday, 21-Sept-2021, a Medical Assistant drew up the expired dose and gave it to one of their providers.
Developed a large red mark on her arm the size of a lemon; Developed a large red mark on her arm the size of a lemon, itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Developed a large red mark on her arm the size of a lemon) and INJECTION SITE PRURITUS (Developed a large red mark on her arm the size of a lemon, itchy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Developed a large red mark on her arm the size of a lemon) and INJECTION SITE PRURITUS (Developed a large red mark on her arm the size of a lemon, itchy). On 25-Jan-2021, INJECTION SITE ERYTHEMA (Developed a large red mark on her arm the size of a lemon) and INJECTION SITE PRURITUS (Developed a large red mark on her arm the size of a lemon, itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Bells palsy left side of face.  Droopy, can not blink, jaw soreness, some drooling
hot flashes; excessive sweating; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient received BNT162b2 (BNT162B2), on 26Feb2022 as dose 3 (booster), single (Lot number: FL3209) at the age of 61 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (dose 2, Batch/Lot No: EW0170), administration date: 20Apr2021, when the patient was 60-year-old, for COVID-19 Immunization; BNT162b2 (dose 1, Batch/Lot No: ER8732), administration date: 30Mar2021, when the patient was 60-year-old, for COVID-19 Immunization. The following information was reported: HYPERHIDROSIS (non-serious) with onset 26Feb2022, outcome "recovered" (2022), described as "excessive sweating"; HOT FLUSH (non-serious) with onset 26Feb2022, outcome "recovered" (2022), described as "hot flashes". Therapeutic measures were not taken as a result of hot flush, hyperhidrosis.  No follow-up attempts are possible. No further information is expected.
I had coldness in whole body, numbness in hands more so the right hand, right hand elbow and wrist have soreness.
24hrs after administration of vaccine, I experienced muscle aches/stiffness and runny nose. Now a week later, I have an elevated, warm red mark about 2in x 2in on my L arm at the site of injection that is also itchy.
Information has been received from a physician concerning a 66 year old female who on 16-JUN-2006 was vaccinated subcutaneously with a 0.5mL dose of Pneumovax 23 (lot 651357/0391F). The physician reported that after receiving Pneumovax 23, the patient developed a swollen arm that shifted down to her elbow. The patient sought medical attention, and an x-ray was performed. At the time of this report, the patient was recovering. Additional information has been requested.
NO ADVERSE REACYTION WHATSOEVER!!  JUST GOT SLIGHTLY EXPIRED VACCINE
Pt. received imm. on 1-23-12 about 9:15 AM. Mom called back around 2:30p child very fussy, no fever, no rash, no redness or swelling to inj. site, not consolable for several hours. Saw pt. and exam WNL except for tenderness on legs. 1/24/12 Still fussy, somewhat consolable, temp - 99.8. Well, no other sx.
Fever x 2 days, body rash x 2 days. Follow up states: Do not have lot numbers to vaccine given
Received immunizations on 07/18/2003 around 12:30pm on 07/19/2003. Told dad he didn't feel good. Five minutes later found in bedroom having febrile seizure.  T101.9
Pt recvd Td vax & exp a skin ulcer @ the site of inject w/in 24 hrs; The ulcer resolved w/in 3 days; No treatment was necessary;
When I received the shot I became very hot  and sweaty. Then I went to the bathroom and when I stood up, I got really dizzy and had to sit down for a minute.  Then I went outside were it was freezing and then got in the car and cut the AC on.  It was almost an hour later from the time I received the vaccine and then the heat finally left and I felt back to normal.
Patient reported thicken tongue and lip tingling. Patient complained of not feeling right or well 10 minutes after vaccination . Patient was given epi and Benadryl  sent to ER . Patient reported no history of allergy to anything
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 1-year-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the vaccines hepatitis a vaccine, inactivated(VAQTA) (lot # S019435 with expiration date 23-AUG-2020, lot # S026003 with expiration date 17-OCT-2020, and lot # S032056 with expiration date 09-NOV-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) 25/0.5 dosage form at a dose of 0.5 ml (route not provided) for prophylaxis. No adverse events were reported.  This is one of several cases from the same reporter.  combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; manufactureraddress: ; manufacturercity: ; manufacturerstate: ; manufacturercountry: ; devicelotnumber: S019435; expirationdate: 23-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004521: US-009507513-2005USA004522: US-009507513-2005USA004524: US-009507513-2005USA004525: US-009507513-2005USA004526: US-009507513-2005USA004527: US-009507513-2005USA004528: US-009507513-2005USA004529: US-009507513-2005USA004530: US-009507513-2005USA004531: US-009507513-2005USA004532: US-009507513-2005USA004533: US-009507513-2005USA004534: US-009507513-2005USA004535: US-009507513-2005USA004536:
arm was sore for one week; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 26-JUL-2022 Reporter's Comments: The health care professional shared his own personal experience following the 1st dose of Shingrix.  He said his arm was sore for one week. The reporter did not consent to follow up.
Body Aches, Headache, Congestion, Fever, Right Eye Swollen
Bloody nose, high fever, sets alarms off when going in and out of store, alarm goes off when he passes if car has an alarm it and then he has a headache afterwards
A report has been received from a Health Professional concerning a 13 year old, Female subject, who had been receiving Nasal FLUMIST quadrivalent started on 17-Aug-2013. The patient experienced nasal congestion which started on 20-Aug-2013. The outcome of the event nasal congestion is unknown. The report was considered to be non-serious.
5 minutes after my 2nd dose - I cannot breathe since it was a drive thru, I had to press the horn to ask for help and when people came up, they said my face was so red. Then I told them I can't breathe, and they went inside my car, and they gave me an EpiPen for my left leg and then I felt that I couldn't breathe again, and I grabbed the nurse's shirt because I felt that I did not have any oxygen and after that they gave another EpiPen I had seizure and blacked out. They called 911 and I had 4-5 seizures on the way to the hospital. The hospital did some CT scan, MRI, and some other tests and it was discovered that I have a trigger (which was the vaccine - because it hit my nerves) other than that I was perfectly healthy but after I went home, I had a seizure again and it still happens frequently up to this day. I take Keppra (1500 mg) and Gabapentin for nerve pain.
Systemic: Chills-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Medium, Systemic: Vomiting-Medium
28-year-old male with a history of childhood asthma without exacerbations in adulthood presenting with intermittent chest tightness and mild shortness of breath x3 days post Maderna COVID booster.  This morning, pain was localized to sternal chest region and was mildly worse than the 2 prior days.  Patient endorses mild left axillary pain.  There is no associated cough, painful inspiration, headache, fever/chills, nausea/vomiting.  Patient states he is asymptomatic prior to COVID booster.  His biological father passed away a year ago secondary to COVID complications.
Patient presented initially to his PCP on 4/24/21 for on going muscle aches after his COVID vaccine. Pain is on other arms, takes tylenol for treatment but no relief. Blood pressure elevated at the time of visit, no limited ROM, bruising present. Patient denies sx of cough, fever, SOB or chills, chest pain/pressure, GI or GU issues, HA.  Patient provided prescription for celecoxib 200mg PO daily prn pain.    Presented to hospital emergency room on 4/27/21 for chest pain, found to have anterior wall STEMI.  The patient was started on IV heparin and medical therapy with intravenous beta-blocker before being transferred to another healthcare facility.  His initial troponin was 0.2.  His CBC with diff and electrolytes are all within normal limits.  Patient was immediately taken to the cath lab for PCI. In route to hospital the patient was given 1 dose of nitroglycerin, aspirin, morphine for pain.  Cardiac catheterization was performed with placement of drug-eluting stent into the Mid LAD.  Patient started on aspirin and Brilinta.  Echocardiogram showed mild left ventricular hypertrophy, severe mid to distal anterior septal hypokinesis, apical akinesis with an EF of 45 to 50% and grade 2 diastolic dysfunction.  Patient has had no return of his symptoms since the PCI, tolerated p.o. intake without difficulty.  No nausea/vomiting, or shortness of breath.  Able to ambulate without difficulty.
pt recv vax; approx 24 hr later, feeling of "chills" & n for few hr then pain in neck w/ mild spasms, gone next day 24-48 hr p/ shot; 1 1/2" induration/redness at site;
developing arthritis or increasing the arthritis/developed arthritis in 4 different places; joint pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 16Jul2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE; MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: ARTHRITIS (non-serious), outcome "unknown", described as "developing arthritis or increasing the arthritis/developed arthritis in 4 different places"; ARTHRALGIA (non-serious), outcome "unknown", described as "joint pain".  Additional information: the patient asked if the COVID vaccine had any relation to the developing arthritis or increasing the arthritis, since the patient got his 4th booster and 2 weeks later he developed arthritis in 4 different places. He wanted to know if the joint pain that were reported was a solid evidence associating the vaccine to arthritis, before he gets the omicron.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mother reported child with full body rash 1 day after admin of flu vacc. Child without fever or any other symptoms especially site specific reaction.
Within one minute post administering second in series of Hep A pediatric doses pt. lost consciousness, foaming at lips, no tonic or clonic movement.
This spontaneous case reported by a consumer, describes the occurrence of rash (both arms, eyes and left cheek) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 007B21A) for COVID-19 immunization. No medical history reported. On Mar 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 25, 2021, patient experienced rash (both arms, eyes and left cheek). At the time of the report, rash (both arms, eyes and left cheek): unresolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medication list not provided. Treatment provided include allergy medication. Most recent follow-up information incorporated: On May 20, 2021: Follow-up received on May 20, 2021. Reporter's email address added. It contains non-significant information.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 02-DEC-2015 during the same office visit, the patient was vaccinated with two doses of GARDASIL lot # K005083, expiration date: 04-NOV-2015, intramuscularly, one in the left arm and one in the right arm. These are the only doses of GARDASIL this patient has ever been administered. No adverse effect was reported. Additional information has been requested.
started having symptoms for Shingles approximately 2 weeks 3 days after receiving 1st vaccine. I was diagnosed 4 days later; This is a spontaneous report from a contactable consumer (patient) reporting herself.  A 48-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EL9262) via an unspecified route of administration, administered in Arm Left on 28Jan2021 at 07:45 as SINGLE DOSE for covid-19 immunization. Medical history included colon cancer, hypothyroidism and hypertension. Concomitant medication in two weeks included thyroid (ARMOUR THYROID); sertraline (SERTRALINE) and hydrochlorothiazide (HYDROCHLOROTHIAZIDE). The patient did not receive any other vaccines in four weeks. The patient previously took Vicadine and experienced known allergies: Vicadine. On 14Feb2021, the patient experienced, started having symptoms for shingles approximately 2 weeks 3 days after receiving 1st vaccine and was diagnosed 4 days later. The patient not had covid prior vaccination; not tested covid post vaccination. Therapeutic measures were taken as a result of event and included treatment with Medication. The patient visited a Physician Office. The outcome of event is recovering.
This case was reported by a pharmacist and described the occurrence of breast cancer in a 55-year-old female patient who received ENGERIX B adult. Concomitant products included ENGERIX B adult, oxycodone, CYTOXAN, DECADRON, Vitamin D3, calcium and MIRALAX. On an unknown date, the patient received the 2nd dose of ENGERIX B adult. On an unknown date, an unknown time after receiving ENGERIX B adult, the patient experienced breast cancer (serious criteria GSK medically significant). The patient was treated with medication unknown (Unspecified Treatment). On an unknown date, the outcome of the breast cancer was unknown. The reporter considered the breast cancer to be unrelated to ENGERIX B adult. Additional details provided: Patient's concomitant products included also XANAX and fosprepitant. There was unknown if other vaccines were given on the same date. The patient's relevant medical history was unknown. On 24 November 2014, the patient received FLUARIX QUADRIVALENT. The patient was started on ENGERIX-B and received 2 doses. She was now due for her third dose but she was currently on breast cancer treatment. She was not on breast cancer treatment prior to starting the ENGERIX-B series. It is unknown whether she was diagnosed with breast cancer before or after starting the series of ENGERIX-B. The reporter stated that was "impossible" that her breast cancer was due to ENGERIX-B. The patient was currently on the 4th cycle of treatment for breast cancer. The Immunization was given in a different facility/clinic.
RN BSN gave the student his flu vaccine (authorization signed) 11/05/2021 at 1000. Another RN BSN had preciously reported she checked and that the student had not received his flu vaccine this year. When RN BSN placed the given vaccine into syringe she noted a flu vaccine had already been administered 10/26/2021 in a clinic. RN BSN reports she looked at the wrong patient in prior to releasing the student for his vaccine.
Left retrobulbar optic neuritis manifesting with visual disturbance (but no visual field defects) and pain with eye movement. Symptom onset may have preceded vaccination. By the time the diagnosis was made, it was unclear when the symptoms had started, but it was close in time to vaccination. Common causes of ON such as MS, etc. were ruled out.  The vaccination was the third dose (booster) of Moderna given about 9 months after the second dose.
Information has been received from a pharmacist concerning a patient of unknown age and gender. There was no information about concurrent condition, medical history or concomitant medication. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX23 injection (lot #, dosage and route not reported). On an unknown date the patient had allergic reaction to PNEUMOVAX23. It was not a severe allergic reaction. The outcome of the event was not reported. Action taken was not applicable. Additional information has been requested.
Information has been received from a physician concerning a 16 year old female with asthma and allergy to "campha" who on 16, Feb 2007 was vaccinated IM with her first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast), single dose vial. Concomitant therapy included fluticasone propionate (+) salmeterol xinafoate (ADVAIR) and amphetamine aspartate/amphetamineSO4/dex (ADDERALL TABLETS). On 27, Feb 2007 the patient was tested for HPV and the pap smear results were positive for high risk HPV. Unspecified medical attention was sought. Her outcome was unknown. Additional information has been requested.
Patient reported muscle aches, weakness, HA, fatigue, chills, fever. No respiratory involvement. Reported symptoms started on 11-12-11. Received injection on 11-9-11. Pt reported: not exposed to anyone with flu symptoms.
MODERNA COVID-19 VACCINE EUA  DIME TO QUARTER SIZED ITCHY SPOTS (HIVES) ON BOTH WRISTS, LEFT HIP, UNDER RIGHT BUTT CHEEK, INSIDE RIGHT ELBOW, BACK OF LEFT UPPER ARM.  WERE ALWAYS THERE BUT DIDN'T ITCHY ALL AT ONCE OR ALL THE TIME.  WOULD GET RED, INFLAMED, WELT UP, ITCH HORRIBLY INTERMITTANTLY.  PIN POINT SIZED ITCHY SPOTS WOULD ERRUPT ON DIFFERENT PARTS OF THE BODY, RANDOMLY FOR A DAY, THEN DISAPPEAR.  BENEDRYL CREAM STOPPED THE ITCHING, BUT THE WELTS ARE STILL THERE